References

Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia

10.1097/mcc.0000000000000526 · 2018 · External reference

The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update

10.1007/s40265-021-01635-6 · 2021 · External reference

Unresolved reference

2023 · External reference

Clinical outcomes after initial Pseudomonas acquisition in cystic fibrosis

10.1002/ppul.23036 · 2015 · External reference

Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosis

10.1093/infdis/jiae051 · 2024 · External reference

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

10.1086/533452 · 2008 · External reference

The virulence of Pseudomonas aeruginosa

10.1093/clinids/6.supplement_3.s617 · 1984 · External reference

A systematic review and meta-analysis on Exo-toxins prevalence in hospital acquired Pseudomonas aeruginosa isolates

10.1016/j.meegid.2019.104037 · 2019 · External reference

Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin a with mortality in cystic fibrosis

10.1164/arrd.1986.133.4.648 · 1986 · External reference

Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo

10.1128/iai.15.1.138-144.1977 · 1977 · External reference

Furin activates Pseudomonas exotoxin a by specific cleavage in vivo and in vitro

10.1016/s0021-9258(18)31770-8 · 1994 · External reference

Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases

10.1128/iai.63.1.82-87.1995 · 1995 · External reference

Association of the exotoxin a and exoenzyme S with antimicrobial resistance in Pseudomonas aeruginosa strains

10.1016/j.burns.2016.02.012 · 2016 · External reference

Exoenzyme T plays a pivotal role in the IFN-gamma production after Pseudomonas challenge in IL-12 primed natural killer cells

10.3389/fimmu.2017.01283 · 2017 · External reference

Pseudomonas aeruginosa ExoT induces mitochondrial apoptosis in target host cells in a manner that depends on its GTPase-activating protein (GAP) domain activity

10.1074/jbc.m115.689950 · 2015 · External reference

A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease

10.1016/j.chembiol.2022.02.001 · 2022 · External reference

Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections

10.1126/sciadv.ade8039 · 2023 · External reference

Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis

10.1165/rcmb.2008-0295oc · 2009 · External reference

Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury

10.1172/jci.insight.98178 · 2018 · External reference

NIH Image to ImageJ: 25 years of image analysis

10.1038/nmeth.2089 · 2012 · External reference

Epithelial sodium channels are activated by furin-dependent proteolysis

10.1074/jbc.c400080200 · 2004 · External reference

Regulation of toxA by PtxR in Pseudomonas aeruginosa PA103

10.1139/w03-058 · 2003 · External reference

Use of cellular glucose-6-phosphate dehydrogenase for cell quantitation: applications in cytotoxicity and apoptosis assays

10.1016/j.ab.2004.02.007 · 2004 · External reference

Extracellular histones are major mediators of death in sepsis

10.1038/nm.2053 · 2009 · External reference

Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis

10.1371/journal.pone.0148142 · 2016 · External reference

Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa

10.1152/ajplung.00335.2013 · 2014 · External reference

New insights on Pseudomonas aeruginosa exotoxin A-based immunotoxins in targeted cancer therapeutic delivery

10.4155/tde-2022-0055 · 2023 · External reference

The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin a in vivo

10.1128/iai.70.12.7136-7139.2002 · 2002 · External reference

Development and prospects of furin inhibitors for therapeutic applications

10.3390/ijms25179199 · 2024 · External reference

Semaphorin 3E-plexin D1 axis drives lung fibrosis through ErbB2-mediated fibroblast activation

10.1002/advs.202415007 · 2025 · External reference

Pseudomonas aeruginosa: infections and novel approaches to treatment “knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment

10.1016/j.imj.2023.05.003 · 2023 · External reference

COPD immunopathology

10.1007/s00281-016-0561-5 · 2016 · External reference

Role of alveolar ­macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia

10.1128/iai.66.7.3164-3169.1998 · 1998 · External reference

Alveolar macrophage phagocytosis and bacteria clearance in mice

10.3791/59088 · 2019 · External reference

Effects of CFTR ­modulators on Pseudomonas aeruginosa infections in cystic ­fibrosis

10.3390/idr17040080 · 2025 · External reference

Depletion of alveolar macrophages increases pulmonary neutrophil infiltration, tissue damage, and sepsis in a murine model of Acinetobacter baumannii pneumonia

10.1128/iai.00128-20 · 2020 · External reference

Cytochrome P450 1A1 enhances inflammatory responses and impedes phagocytosis of bacteria in macrophages during sepsis

10.1186/s12964-020-00597-8 · 2020 · External reference

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

10.1182/blood-2018-03-838474 · 2018 · External reference

Neutrophil extracellular traps induce MCP-1 at the culprit site in ST-segment elevation myocardial infarction

10.3389/fcell.2020.564169 · 2020 · External reference

Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis

10.1172/jci18125 · 2003 · External reference

Innate lymphoid cells and natural killer cells in bacterial infections: function, dysregulation, and therapeutic targets

10.3389/fcimb.2021.733564 · 2021 · External reference

NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice

10.4049/jimmunol.172.5.3034 · 2004 · External reference

Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease

10.1371/journal.pone.0103840 · 2014 · External reference

Lung dendritic cells drive natural killer cytotoxicity in chronic obstructive pulmonary disease via IL-15Ralpha

10.1164/rccm.201712-2513oc · 2018 · External reference

Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury

10.1172/jci137047 · 2021 · External reference

Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model

10.1097/ccm.0000000000000311 · 2014 · External reference

BOS-318 treatment enhances elexacaftor-tezacaftor-ivacaftor-mediated improvements in airway hydration and mucociliary transport

10.1183/23120541.00445-2024 · 2025 · External reference

Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice

10.1186/1465-9921-11-166 · 2010 · External reference

A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia

10.1203/00006450-198712000-00017 · 1987 · External reference

Mouse models of chronic lung infection with Pseudomonas aeruginosa: ­models for the study of cystic fibrosis

10.1002/1099-0496(200011)30:5<413::aid-ppul8>3.0.co;2-9 · 2000 · External reference

Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase furin

10.1242/dev.125.24.4863 · 1998 · External reference

Proprotein convertases: lessons from knockouts

10.1096/fj.05-5491rev · 2006 · External reference

Loss of endothelial furin leads to cardiac malformation and early postnatal death

10.1128/mcb.06331-11 · 2012 · External reference